Answer:
kahilaan mu pong i show yung story to us para ma sagot namin. thank you po!
Answer:
Hello. You did not put the answer options, but the role of moss in the transition to stage III is the creation of protonemes where the gametes that will act in stage III will be formed.
Explanation:
Stage III consists of the fertilization of the female gamete of the moss with the male gamete of another moss, thus creating a zygote that will give rise to other mosses in the future.
Moss is very important for this phase, because it will be responsible for creating a structure called protonemas. In the protonemas are the gametophytes that will have a structure called gametangium that will allow the formation of gametes.
Double-blind design: this is how the study will be conducted. This means that in this study, participants will know which treatments are being applied to each participant. In this case, the researcher can hire a doctor or health professional who can deliver the different treatments to the participants without the researcher and the participants themselves knowing what treatment is being delivered and which participants are not receiving any treatment.
Antagonist: It will be a substance used to establish connections in the participants' neurological receptors, but without activating these receptors and preventing any other substance from activating them.
Acetylcholine: Will be the neurotransmitter tested in treatments, as it is the main neurotransmitter often related to the symptoms of Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia
Positron Emission Tomography (PET): It will allow the visualization of images that will allow the evaluation of the functioning of the neurotransmitters related to each tested treatment.
Blood-brain barrier: It will allow the assessment of the metabolic function of the participants' brain, as it protects the nervous system from toxic and harmful substances. This cerebral metabolic function will be evaluated in relation to each treatment applied.
Myelin sheath: is the protective layer of nerve cells. It is usually damaged in people who have Parkinson's disease, alzheimer's disease, multiple sclerosis and schizophrenia, for this reason, it will allow the assessment of their protection in relation to each treatment tested.
This person would have to be in 1990 B.C., because when in B.C., as the years go by, the number of the year gets lower. So the person was 10 in 1995 B.C., and 15 in 1900 B.C.
